|
1
|
Steinberg H and Wagner A: Hans Steinert:
100 years of myotonic dystrophy. Nervenarzt. 79:961–962. 2008.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pavićević D Savić, Miladinović J,
Brkušanin M, Šviković S, Djurica S, Brajušković G and Romac S:
Molecular genetics and genetic testing in myotonic dystrophy type
1. Biomed Res Int. 2013:3918212013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valaperta R, Sansone V, Lombardi F,
Verdelli C, Colombo A, Valisi M, Brigonzi E, Costa E and Meola G:
Identification and characterization of DM1 patients by a new
diagnostic certified assay: Neuromuscular and cardiac assessments.
Biomed Res Int. 2013:9585102013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ricker K, Koch MC, Lehmann-Horn F,
Pongratz D, Otto M, Heine R and Moxley RT: 3rd: Proximal myotonic
myopathy: A new dominant disorder with myotonia, muscle weakness,
and cataracts. Neurology. 44:1448–1452. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamsteeg EJ, Kress W, Catalli C, Hertz JM,
Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M and
Scheffer H: Best practice guidelines and recommendations on the
molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum
Genet. 20:1203–1208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liquori CL, Ricker K, Moseley ML, Jacobsen
JF, Kress W, Naylor SL, Day JW and Ranum LP: Myotonic dystrophy
type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science.
293:864–867. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurosaki T, Ueda S, Ishida T, Abe K, Ohno
K and Matsuura T: The unstable CCTG repeat responsible for myotonic
dystrophy type 2 originates from an AluSx element insertion into an
early primate genome. PLoS One. 7:e383792012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Machuca-Tzili L, Brook D and Hilton-Jones
D: Clinical and molecular aspects of the myotonic dystrophies: A
review. Muscle Nerve. 32:1–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Logigian EL, Blood CL, Dilek N, Martens
WB, Moxley RTIV, Wiegner AW, Thornton CA and Moxley RT III:
Quantitative analysis of the ‘warm-up’ phenomenon in myotonic
dystrophy type 1. Muscle Nerve. 32:35–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meola G: Clinical aspects, molecular
pathomechanisms and management of myotonic dystrophies. Acta Myol.
32:154–165. 2013.PubMed/NCBI
|
|
11
|
Udd B, Meola G, Krahe R, Wansink DG,
Bassez G, Kress W, Schoser B and Moxley R: Myotonic dystrophy type
2 (DM2) and related disorders report of the 180th ENMC workshop
including guidelines on diagnostics and management 3–5 December
2010, Naarden, The Netherlands. Neuromuscul Disord. 21:443–450.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Wang Z, Cui F, Yang F, Chen Z, Ling
L, Pu C and Huang X: Investigation of molecular diagnosis in
Chinese patients with myotonic dystrophy type 1. Chin Med J (Engl).
127:1084–1088. 2014.PubMed/NCBI
|
|
13
|
Addis M, Serrenti M, Meloni C, Cau M and
Melis MA: Triplet-primed PCR is more sensitive than southern
blotting-long PCR for the diagnosis of myotonic dystrophy type 1.
Genet Test Mol Biomarkers. 16:1428–1431. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh S, Zhang A, Dlouhy S and Bai S:
Detection of large expansions in myotonic dystrophy type 1 using
triplet primed PCR. Front Genet. 5:942014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Turner C and Hilton-Jones D: The myotonic
dystrophies: Diagnosis and management. J Neurol Neurosurg
Psychiatry. 81:358–367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ashizawa T: Myotonic dystrophy as a brain
disorder. Arch Neurol. 55:291–293. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steyaert J, Umans S, Willekens D, Legius
E, Pijkels E, de Die-Smulders C, Van den Berghe H and Fryns JP: A
study of the cognitive and psychological profile in 16 children
with congenital or juvenile myotonic dystrophy. Clin Genet.
52:135–141. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krishnan AV and Kiernan MC: Axonal
function and activity-dependent excitability changes in myotonic
dystrophy. Muscle Nerve. 33:627–636. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lund M, Diaz LJ, Ranthe MF, Petri H, Duno
M, Juncker I, Eiberg H, Vissing J, Bundgaard H, Wohlfahrt J and
Melbye M: Cardiac involvement in myotonic dystrophy: A nationwide
cohort study. Eur Heart J. 35:2158–2164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Phillips MF and Harper PS: Cardiac disease
in myotonic dystrophy. Cardiovasc Res. 33:13–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Douniol M, Jacquette A, Cohen D, Bodeau N,
Rachidi L, Angeard N, Cuisset JM, Vallée L, Eymard B, Plaza M, et
al: Psychiatric and cognitive phenotype of childhood myotonic
dystrophy type 1. Dev Med Child Neurol. 54:905–911. 2012.
View Article : Google Scholar : PubMed/NCBI
|
